This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
clinical signs | 1474 |
mg kg | 658 |
may occur | 316 |
dendritic cells | 293 |
may also | 250 |
weight loss | 248 |
lymph nodes | 212 |
small intestine | 205 |
differential diagnosis | 204 |
gastrointestinal tract | 200 |
united states | 182 |
dendritic cell | 181 |
type lectin | 171 |
small intestinal | 171 |
kg iv | 152 |
immunodeficiency virus | 148 |
foreign bodies | 147 |
also may | 144 |
research complications | 136 |
may cause | 134 |
human immunodeficiency | 133 |
physical examination | 126 |
may result | 123 |
ml kg | 122 |
immune system | 121 |
foreign body | 119 |
affected animals | 117 |
definitive diagnosis | 116 |
one study | 115 |
signs include | 113 |
supportive care | 113 |
type lectins | 111 |
endothelial cells | 109 |
spinal cord | 109 |
large intestine | 107 |
cell surface | 104 |
see chapter | 103 |
abdominal pain | 103 |
laboratory animal | 103 |
immune response | 99 |
mast cell | 99 |
bone marrow | 98 |
epithelial cells | 97 |
kg po | 97 |
differential diagnoses | 95 |
every hours | 95 |
virus infection | 93 |
neck domain | 91 |
virus type | 90 |
may develop | 89 |
animals may | 87 |
fluid therapy | 86 |
nervous system | 85 |
signs may | 85 |
renal failure | 84 |
blood flow | 84 |
activated charcoal | 83 |
cell tumors | 82 |
infected animals | 81 |
immune responses | 81 |
orogastric lavage | 80 |
may require | 80 |
peritoneal fluid | 79 |
mucous membranes | 79 |
respiratory tract | 79 |
severe cases | 79 |
metabolic acidosis | 78 |
bowel disease | 78 |
heart rate | 78 |
antibiotic therapy | 77 |
repeat units | 77 |
blood pressure | 77 |
side effects | 76 |
may include | 76 |
necropsy findings | 76 |
liver disease | 76 |
one may | 76 |
viral infection | 75 |
large colon | 75 |
respiratory distress | 75 |
clinical disease | 75 |
pulmonary edema | 74 |
intravenous fluids | 74 |
head tilt | 74 |
inflammatory response | 74 |
life cycle | 73 |
immunodeficient mice | 71 |
inflammatory bowel | 70 |
middle ear | 69 |
adhesion molecule | 68 |
may reveal | 67 |
intestinal obstruction | 67 |
may appear | 67 |
underlying cause | 66 |
animal medicine | 66 |
acute respiratory | 65 |
amino acid | 64 |
see section | 64 |
respiratory syndrome | 64 |
hepatic lipidosis | 64 |
see table | 64 |
perfringens type | 63 |
intercellular adhesion | 63 |
laboratory mice | 63 |
disease may | 63 |
dengue virus | 63 |
central nervous | 62 |
lymph node | 62 |
many cases | 61 |
bacterial infection | 61 |
escherichia coli | 60 |
guinea pigs | 60 |
may become | 60 |
supplemental oxygen | 59 |
also occur | 58 |
pleural effusion | 58 |
body weight | 58 |
soft tissue | 57 |
gastrointestinal disease | 57 |
commonly used | 57 |
langerhans cells | 57 |
severe acute | 57 |
human beings | 57 |
grabbing nonintegrin | 57 |
clostridium perfringens | 56 |
small ruminants | 56 |
secondary bacterial | 56 |
intestinal tract | 56 |
common cause | 55 |
within hours | 55 |
general anesthesia | 55 |
cell carcinoma | 54 |
cell lines | 54 |
blood cell | 53 |
whenever possible | 53 |
adrenal gland | 53 |
whole blood | 53 |
key point | 53 |
cell lymphoma | 51 |
squamous cell | 51 |
small animal | 51 |
innate immune | 50 |
animals will | 50 |
otitis media | 50 |
heart failure | 50 |
peripheral vestibular | 50 |
large intestinal | 49 |
red blood | 49 |
ear canal | 49 |
pathologic findings | 49 |
may lead | 49 |
infection may | 49 |
commercially available | 49 |
disease process | 49 |
target cells | 49 |
several days | 49 |
important role | 49 |
adult horses | 48 |
small cell | 48 |
influenza virus | 48 |
human dendritic | 48 |
body temperature | 48 |
naturally occurring | 48 |
specific intercellular | 48 |
induce emesis | 47 |
less common | 47 |
specific icam | 46 |
treatment consists | 46 |
direct contact | 46 |
mg dl | 46 |
amino acids | 45 |
body mass | 45 |
animal lectins | 45 |
crystalloid fluids | 45 |
diabetes mellitus | 45 |
gastric ulceration | 45 |
complete blood | 44 |
mast cells | 44 |
intestinal mucosa | 44 |
bacterial infections | 44 |
mesenteric lymph | 44 |
polymerase chain | 44 |
sialic acid | 44 |
perform orogastric | 44 |
determine whether | 43 |
viral infections | 43 |
chain reaction | 43 |
cardiac output | 43 |
infectious diseases | 43 |
lamina propria | 43 |
blood cells | 43 |
kg day | 43 |
north america | 42 |
acute onset | 42 |
kg orally | 42 |
clostridium difficile | 42 |
nasal discharge | 42 |
laboratory animals | 42 |
urinary tract | 42 |
administer intravenous | 42 |
incubation period | 42 |
kg hour | 41 |
vestibular signs | 41 |
surgical intervention | 41 |
cord uid | 41 |
doc id | 41 |
gland disease | 41 |
lectin receptors | 41 |
rectal prolapse | 41 |
signs associated | 41 |
vestibular disease | 41 |
kg body | 40 |
within days | 40 |
carbohydrate recognition | 40 |
helicobacter spp | 40 |
host cells | 40 |
intravenous fluid | 40 |
inner ear | 40 |
gastric emptying | 40 |
smooth muscle | 40 |
reperfusion injury | 40 |
retrospective study | 40 |
white blood | 40 |
linked glycosylation | 39 |
respiratory disease | 39 |
binding sites | 39 |
host cell | 39 |
infectious agents | 39 |
linear foreign | 39 |
flunixin meglumine | 38 |
glycosylation sites | 38 |
antiviral activity | 38 |
ng ml | 38 |
nonsteroidal antiinflammatory | 38 |
spike protein | 38 |
fatty acids | 38 |
blood count | 38 |
septic peritonitis | 38 |
aspiration pneumonia | 38 |
binding site | 38 |
intestinal disease | 38 |
clinical sign | 37 |
infected mice | 37 |
cause severe | 37 |
kg minute | 37 |
arterial blood | 37 |
lesions may | 37 |
central vestibular | 37 |
large numbers | 37 |
large amounts | 37 |
protein concentration | 37 |
may help | 37 |
peritoneal cavity | 37 |
viral entry | 37 |
respiratory syncytial | 37 |
neurologic signs | 37 |
electrolyte abnormalities | 37 |
body condition | 37 |
presumptive diagnosis | 36 |
systemic signs | 36 |
recent study | 36 |
mm hg | 36 |
risk factors | 36 |
mammary tumors | 36 |
several weeks | 36 |
common causes | 36 |
findings include | 36 |
sign expression | 35 |
mice may | 35 |
nutritional support | 35 |
binding protein | 35 |
cell types | 35 |
lesions include | 35 |
upper respiratory | 35 |
ebola virus | 35 |
gauge needle | 35 |
may show | 35 |
surgical removal | 35 |
adult mice | 35 |
repeat unit | 35 |
cell count | 34 |
research setting | 34 |
intravenous crystalloid | 34 |
spectrum antibiotics | 34 |
skin lesions | 34 |
inflammatory mediators | 34 |
host lectins | 34 |
inbred strains | 34 |
often present | 34 |
biomedical research | 34 |
chronic disease | 34 |
syncytial virus | 34 |
common clinical | 34 |
young animals | 34 |
mucosal injury | 34 |
ipa infection | 34 |
nitric oxide | 34 |
intravascular coagulation | 33 |
blood loss | 33 |
diagnostic tests | 33 |
small colon | 33 |
mycobacterium tuberculosis | 33 |
examination findings | 33 |
cell membrane | 33 |
may provide | 33 |
biopsy samples | 33 |
urinary bladder | 33 |
oral cavity | 33 |
tympanic bulla | 33 |
target cell | 33 |
grabbing non | 33 |
serum biochemical | 33 |
vestibular dysfunction | 33 |
mononuclear cells | 33 |
intestinal wall | 33 |
blood glucose | 33 |
also known | 33 |
type ii | 32 |
envelope glycoprotein | 32 |
binding lectin | 32 |
gross lesions | 32 |
abdominal cavity | 32 |
older animals | 32 |
ferrets may | 32 |
therapy may | 32 |
carbon dioxide | 32 |
surgical correction | 32 |
bacterial culture | 32 |
lectin dc | 32 |
pregnancy toxemia | 32 |
surfactant protein | 32 |
esophageal sphincter | 32 |
abdominal wall | 32 |
thoracic radiographs | 32 |
large bowel | 32 |
underlying disease | 32 |
internal medicine | 32 |
peripheral blood | 31 |
per day | 31 |
neurological signs | 31 |
syndrome coronavirus | 31 |
frozen plasma | 31 |
disseminated intravascular | 31 |
diagnoses include | 31 |
immunocompetent mice | 31 |
may contribute | 31 |
congestive heart | 31 |
local anesthetic | 31 |
gastric ulcers | 31 |
become infected | 31 |
medical therapy | 31 |
cause diarrhea | 31 |
surgical resection | 31 |
electrolyte imbalances | 31 |
vascular permeability | 31 |
recognition domain | 30 |
feline infectious | 30 |
tissue damage | 30 |
mammary gland | 30 |
mg ml | 30 |
affected area | 30 |
early stages | 30 |
passive immunity | 30 |
fluorescent antibody | 30 |
hemolytic anemia | 30 |
capillary refill | 30 |
antiinflammatory drugs | 30 |
may predispose | 30 |
refill time | 30 |
hiv infection | 30 |
urine output | 30 |
oncotic pressure | 30 |
sodium bicarbonate | 30 |
systemic inflammation | 30 |
usually occurs | 30 |
type i | 29 |
may remain | 29 |
binding agents | 29 |
envelope protein | 29 |
blood vessels | 29 |
blood samples | 29 |
room temperature | 29 |
often associated | 29 |
diarrhea may | 29 |
fresh frozen | 29 |
vertical transmission | 29 |
maintain hydration | 29 |
respiratory rate | 29 |
chronic inflammation | 29 |
scid mice | 29 |
one must | 29 |
envelope glycoproteins | 29 |
lower esophageal | 29 |
will also | 29 |
zoonotic potential | 29 |
ascending colon | 28 |
poor prognosis | 28 |
hair coat | 28 |
commonly affected | 28 |
intravenous catheter | 28 |
nasogastric tube | 28 |
liver enzymes | 28 |
adverse effects | 28 |
several months | 28 |
recent studies | 28 |
sterile saline | 28 |
may play | 28 |
acute phase | 28 |
layer protein | 28 |
gastric mucosa | 28 |
intestinal motility | 28 |
mouse strains | 28 |
twice daily | 28 |
bovis bcg | 28 |
urinary catheter | 28 |
right dorsal | 28 |
lymphoid tissue | 28 |
made based | 28 |
immune cells | 28 |
otitis externa | 28 |
muscle tremors | 27 |
orally every | 27 |
oral administration | 27 |
renal disease | 27 |
persistently infected | 27 |
helicobacter pylori | 27 |
saline solution | 27 |
occurs within | 27 |
mechanical ventilation | 27 |
sudden death | 27 |
lectins dc | 27 |
infectious peritonitis | 27 |
abdominal palpation | 27 |
exploratory laparotomy | 27 |
bl mice | 27 |
lung injury | 27 |
vaginal discharge | 27 |
mucosal barrier | 27 |
occur within | 27 |
infected cells | 27 |
inflammatory cells | 27 |
abdominal distention | 26 |
vena cava | 26 |
urethral obstruction | 26 |
mice infected | 26 |
high doses | 26 |
abdominal radiographs | 26 |
gastric acid | 26 |
emergency care | 26 |
diaphragmatic hernia | 26 |
medical management | 26 |
will often | 26 |
natural infection | 26 |
intestinal contents | 26 |
innate immunity | 26 |
fecal flotation | 26 |
clinically normal | 26 |
pattern recognition | 26 |
candida albicans | 26 |
experimentally infected | 26 |
surface area | 26 |
cell wall | 26 |
skin scrapings | 26 |
cardiac dysrhythmias | 26 |
alveolar macrophages | 26 |
granulomatous enteritis | 26 |
leukemia virus | 26 |
experimentally induced | 26 |
cats may | 25 |
warm water | 25 |
negative bacteria | 25 |
mm nacl | 25 |
less commonly | 25 |
cell culture | 25 |
closely related | 25 |
cell infection | 25 |
tight junction | 25 |
iv cri | 25 |
kg intravenously | 25 |
basement membrane | 25 |
pelvic flexure | 25 |
commonly associated | 25 |
vestibular system | 25 |
treatment may | 25 |
make sure | 25 |
canine distemper | 25 |
inbred strain | 25 |
antibiotic treatment | 25 |
per rectum | 25 |
heartworm disease | 25 |
laboratory mouse | 25 |
lectin interactions | 25 |
disease occurs | 25 |
squamous mucosa | 25 |
radiation therapy | 25 |
mammary glands | 25 |
several studies | 25 |
abdominal fluid | 24 |
total protein | 24 |
may contain | 24 |
mouth disease | 24 |
respiratory signs | 24 |
esophageal obstruction | 24 |
renal function | 24 |
miiuy croaker | 24 |
infectious bovine | 24 |
high mortality | 24 |
viral lectins | 24 |
immunosorbent assay | 24 |
less likely | 24 |
may present | 24 |
kg im | 24 |
initial treatment | 24 |
histopathologic examination | 24 |
acute pancreatitis | 24 |
acute disease | 24 |
milk replacers | 24 |
jugular vein | 24 |
may prevent | 24 |
mineral oil | 24 |
antigen presentation | 24 |
mouse colonies | 24 |
chronic diarrhea | 24 |
external ear | 24 |
transmission occurs | 24 |
clinical illness | 24 |
catheter placement | 24 |
surgical exploration | 24 |
animal models | 23 |
radiographs may | 23 |
beta toxin | 23 |
incidental finding | 23 |
blood gas | 23 |
produced virus | 23 |
clinical course | 23 |
animal practice | 23 |
gastroesophageal reflux | 23 |
intercostal space | 23 |
deficient mice | 23 |
large volumes | 23 |
affected cats | 23 |
vero cells | 23 |
endemic areas | 23 |
athymic mice | 23 |
black disease | 23 |
kg sq | 23 |
virus isolation | 23 |
host defense | 23 |
inflammatory diseases | 23 |
hypovolemic shock | 23 |
tissue perfusion | 23 |
plasma protein | 23 |
may need | 23 |
acute infection | 23 |
measles virus | 23 |
plasma membrane | 23 |
antimicrobial therapy | 23 |
viral envelope | 23 |
weight gain | 23 |
contrast radiography | 23 |
viral particles | 23 |
surgical treatment | 23 |
severe disease | 23 |
monoclonal antibody | 23 |
may increase | 23 |
central venous | 23 |
binding proteins | 23 |
structural basis | 22 |
immune function | 22 |
carrier animals | 22 |
mouse strain | 22 |
iu kg | 22 |
horse fever | 22 |
serum biochemistry | 22 |
supportive therapy | 22 |
left shift | 22 |
include vomiting | 22 |
contagious ecthyma | 22 |
tight junctions | 22 |
facial nerve | 22 |
ulcer disease | 22 |
adult worms | 22 |
ventricular dysrhythmias | 22 |
acute renal | 22 |
may affect | 22 |
rectal palpation | 22 |
crystalloid fluid | 22 |
potomac horse | 22 |
renal perfusion | 22 |
acral lick | 22 |
persistent infection | 22 |
recognition receptors | 22 |
like receptors | 22 |
granulation tissue | 22 |
cell adhesion | 22 |
mg cat | 22 |
anion gap | 22 |
per os | 22 |
like receptor | 22 |
aseptically scrub | 22 |
cerebral edema | 22 |
less severe | 22 |
small bowel | 22 |
goat kids | 22 |
tympanic membrane | 22 |
proliferative enteropathy | 22 |
oxygen delivery | 22 |
electron microscopy | 22 |
strangulating obstruction | 22 |
test results | 22 |
infant mice | 22 |
small amounts | 22 |
anterior chamber | 22 |
older cats | 22 |
hepatic failure | 22 |
high mannose | 22 |
ml syringe | 22 |
cell line | 22 |
diagnosis may | 22 |
simian immunodeficiency | 21 |
postoperative ileus | 21 |
varying degrees | 21 |
cell tumor | 21 |
ventral colon | 21 |
many cats | 21 |
cells expressing | 21 |
blood supply | 21 |
take care | 21 |
reproductive tract | 21 |
chronic inflammatory | 21 |
gel filtration | 21 |
mucous membrane | 21 |
transit time | 21 |
antibody titers | 21 |
viral diarrhea | 21 |
diagnosis requires | 21 |
acid secretion | 21 |
cns excitation | 21 |
bile acids | 21 |
causative agent | 21 |
peritoneal lavage | 21 |
cases may | 21 |
colonic mucosa | 21 |
increased risk | 21 |
male dogs | 21 |
veterinary therapy | 21 |
systemic inflammatory | 21 |
pulse oximetry | 21 |
endothelial cell | 21 |
derived dendritic | 21 |
younger animals | 21 |
mannose receptor | 21 |
wound healing | 21 |
healthy cats | 21 |
lactic acidosis | 21 |
complement fixation | 21 |
constant rate | 21 |
vesicular stomatitis | 21 |
salivary glands | 21 |
intravascular hemolysis | 21 |
virus entry | 21 |
naturally infected | 21 |
long periods | 21 |
fecal culture | 21 |
severe clinical | 21 |
current veterinary | 21 |
section iii | 21 |
three times | 21 |
platelet count | 21 |
hepatic encephalopathy | 21 |
surgical excision | 21 |
mustela putorius | 20 |
enveloped viruses | 20 |
sinusoidal endothelial | 20 |
abdominal ultrasound | 20 |
may produce | 20 |
organ systems | 20 |
severely affected | 20 |
virus strains | 20 |
may take | 20 |
approximately days | 20 |
cytologic examination | 20 |
airway obstruction | 20 |
total body | 20 |
viral replication | 20 |
bovine viral | 20 |
chronic pancreatitis | 20 |
rate infusion | 20 |
iv fluids | 20 |
bile duct | 20 |
systemic disease | 20 |
occur secondary | 20 |
large quantities | 20 |
linked immunosorbent | 20 |
intermediate host | 20 |
expressing cells | 20 |
bordetella bronchiseptica | 20 |
cmv infection | 20 |
control measures | 20 |
affected tissues | 20 |
tritrichomonas foetus | 20 |
show signs | 20 |
critically ill | 20 |
will occur | 20 |
sodium chloride | 20 |
may note | 20 |
membrane fusion | 20 |
also possible | 20 |
plant lectins | 20 |
may exhibit | 20 |
vascular access | 20 |
renal tubular | 20 |
artificial insemination | 20 |
within minutes | 20 |
mucosal ulceration | 20 |
times daily | 20 |
bovine rhinotracheitis | 20 |
acute abdominal | 20 |
term survival | 20 |
virus envelope | 20 |
toxicity include | 20 |
specific treatment | 20 |
signs occur | 20 |
sensitivity testing | 20 |
i i | 20 |
salmonella spp | 19 |
cell volume | 19 |
bite wounds | 19 |
cause clinical | 19 |
repeat domain | 19 |
fecal samples | 19 |
linked glycans | 19 |
cheek teeth | 19 |
endotracheal tube | 19 |
beneficial effects | 19 |
zinc sulfate | 19 |
diarrhea virus | 19 |
liver function | 19 |
source dogs | 19 |
high affinity | 19 |
string suture | 19 |
term prognosis | 19 |
passive transfer | 19 |
control seizures | 19 |
paresis paralysis | 19 |
third eyelid | 19 |
foot rot | 19 |
sars coronavirus | 19 |
infective larvae | 19 |
crystal structure | 19 |
prepatent period | 19 |
small amount | 19 |
previously described | 19 |
helicobacter infection | 19 |
helicobacter species | 19 |
corneal ulcers | 19 |
new animals | 19 |
fluid accumulation | 19 |
may induce | 19 |
exocrine pancreatic | 19 |
modified live | 19 |
cell counts | 19 |
respiratory system | 19 |
susceptibility testing | 19 |
meq kg | 19 |
putorius furo | 19 |
animal health | 19 |
alkaline phosphatase | 19 |
commonly found | 19 |
veterinary medicine | 19 |
packed cell | 19 |
ethylene glycol | 19 |
gastroprotectant drugs | 19 |
infections may | 19 |
xylose absorption | 19 |
helicobacter hepaticus | 19 |
sign may | 19 |
hepatic disease | 19 |
neck region | 19 |
disease virus | 19 |
sarcoptic mange | 19 |
may indicate | 19 |
via dc | 19 |
often occurs | 19 |
es cells | 18 |
interdigital cysts | 18 |
ocular discharge | 18 |
animal may | 18 |
response syndrome | 18 |
burn injury | 18 |
research facility | 18 |
bowel diarrhea | 18 |
highly conserved | 18 |
campylobacter jejuni | 18 |
sign gene | 18 |
pancreatic insufficiency | 18 |
toxic potential | 18 |
intestinal distention | 18 |
found dead | 18 |
abdominal discomfort | 18 |
watery diarrhea | 18 |
surgical procedures | 18 |
hip dysplasia | 18 |
may involve | 18 |
panax ginseng | 18 |
milk replacer | 18 |
glycan deletions | 18 |
adult animals | 18 |
inflammatory disease | 18 |
red rubber | 18 |
first hours | 18 |
also occurs | 18 |
analgesic drugs | 18 |
mm cacl | 18 |
microscopic examination | 18 |
cell cultures | 18 |
high risk | 18 |
septic shock | 18 |
treat supportively | 18 |
cardiac disease | 18 |
gram negative | 18 |
clinical presentation | 18 |
ehrlichia risticii | 18 |
vestibular syndrome | 18 |
sign genes | 18 |
antibody response | 18 |
helicobacter mustelae | 18 |
normal flora | 18 |
readily available | 18 |
high levels | 18 |
glycoprotein gp | 18 |
intravenously every | 18 |
intermediate hosts | 18 |
death may | 18 |
gastric ph | 18 |
chest ct | 18 |
elizabethan collar | 18 |
pathogenic bacteria | 18 |
growth factor | 18 |
pneumocystis carinii | 18 |
liver tissue | 18 |
hair loss | 18 |
chronic infection | 18 |
one case | 18 |
fungal infection | 18 |
lactic acid | 18 |
clinical manifestations | 18 |
immature dendritic | 17 |
squamous epithelium | 17 |
herpes simplex | 17 |
differentials include | 17 |
nsaid toxicity | 17 |
hemorrhagic fever | 17 |
contaminated feed | 17 |
epiploic foramen | 17 |
may reduce | 17 |
high concentrations | 17 |
also cause | 17 |
intestinal inflammation | 17 |
catheter hub | 17 |
intraocular pressure | 17 |
frothy bloat | 17 |
lymphoid tissues | 17 |
tissue necrosis | 17 |
parenteral nutrition | 17 |
virus may | 17 |
rna viruses | 17 |
preventive measures | 17 |
years old | 17 |
foreign object | 17 |
cerebrospinal fluid | 17 |
experimental inoculation | 17 |
bacterial pneumonia | 17 |
milk production | 17 |
intestine may | 17 |
fluid diuresis | 17 |
fluid volume | 17 |
lick granuloma | 17 |
computed tomography | 17 |
upper airway | 17 |
obligate intracellular | 17 |
one also | 17 |
histologic examination | 17 |
include anorexia | 17 |
liver diseases | 17 |
adhesion molecules | 17 |
reactive oxygen | 17 |
sign receptor | 17 |
transcription factor | 17 |
carrier state | 17 |
cns depression | 17 |
increased vascular | 17 |
inflammatory cytokines | 17 |
needle aspiration | 17 |
liver biopsy | 17 |
systemic antibiotics | 17 |
congenital defects | 17 |
glycan shield | 17 |
another study | 17 |
experimental infection | 17 |
dependent manner | 17 |
mild cases | 17 |
tumor cell | 17 |
neutrophilic leukocytosis | 17 |
effective treatment | 17 |
vestibular nuclei | 17 |
treatment includes | 17 |
laboratory setting | 17 |
within hr | 17 |
toxic dose | 17 |
dogs used | 17 |
productive infection | 17 |
fluid loss | 17 |
drinking water | 17 |
enteric nervous | 17 |
cranial nerves | 16 |
salmonella typhimurium | 16 |
serum chemistry | 16 |
barrier function | 16 |
descending colon | 16 |
large animal | 16 |
veterinary internal | 16 |
also called | 16 |
abdominal effusion | 16 |
vaccination programs | 16 |
fatty acid | 16 |
dorsal colon | 16 |
aleutian disease | 16 |
cardiovascular status | 16 |
protein loss | 16 |
wide variety | 16 |
diagnostic tool | 16 |
bacterial products | 16 |
domestic animals | 16 |
anemia may | 16 |
embryo transfer | 16 |
reflux esophagitis | 16 |
adaptive immune | 16 |
human cytomegalovirus | 16 |
cells may | 16 |
usually associated | 16 |
male mice | 16 |
research studies | 16 |
ear mites | 16 |
clotting factors | 16 |
stricture formation | 16 |
factor viii | 16 |
sign binding | 16 |
fluid may | 16 |
even though | 16 |
affected ferrets | 16 |
months old | 16 |
bacterial overgrowth | 16 |
staphylococcus aureus | 16 |
concurrent diseases | 16 |
acid sequence | 16 |
schistosoma mansoni | 16 |
ear disease | 16 |
first week | 16 |
also available | 16 |
fusion protein | 16 |
sensitivity results | 16 |
malignant edema | 16 |
young horses | 16 |
also important | 16 |
breeding season | 16 |
subcutaneous tissues | 16 |
often used | 16 |
experimental studies | 16 |
dead space | 16 |
cranial nerve | 16 |
north american | 16 |
spectrum antibiotic | 16 |
head trauma | 16 |
experimental models | 16 |
largely supportive | 16 |
facial paresis | 16 |
require surgical | 16 |
fibrous tissue | 16 |
infectious disease | 16 |
heparan sulfate | 16 |
mucosal damage | 16 |
examination may | 16 |
gastrointestinal ulceration | 16 |
cell membranes | 16 |
pathogen recognition | 16 |
pcr testing | 16 |
survival time | 16 |
common findings | 16 |
usually present | 16 |
late gestation | 16 |
simplex virus | 16 |
acute colitis | 16 |
pale mucous | 16 |
predisposing factors | 16 |
female mice | 15 |
every days | 15 |
complement cascade | 15 |
disease caused | 15 |
epithelial cell | 15 |
mediated hiv | 15 |
hiv gp | 15 |
right atrium | 15 |
human patients | 15 |
virus glycoprotein | 15 |
lactobacillus acidophilus | 15 |
calcium gluconate | 15 |
culture supernatants | 15 |
research animals | 15 |
regional lymph | 15 |
may accompany | 15 |
gastrointestinal motility | 15 |
environmental contamination | 15 |
motor neuron | 15 |
dairy cattle | 15 |
serologic tests | 15 |
occurs primarily | 15 |
endotracheal intubation | 15 |
medical treatment | 15 |
flow cytometry | 15 |
smaller ruminants | 15 |
contaminated food | 15 |
two cats | 15 |
help prevent | 15 |
animal welfare | 15 |
bred dogs | 15 |
bacillary hemoglobinuria | 15 |
gall bladder | 15 |
absorbable suture | 15 |
proton pump | 15 |
primary immune | 15 |
organisms may | 15 |
systemic infection | 15 |
performed using | 15 |
gene expression | 15 |
aborted fetuses | 15 |
tract disease | 15 |
pulmonary artery | 15 |
corynebacterium pseudotuberculosis | 15 |
gastrointestinal diseases | 15 |
wound management | 15 |
surgical management | 15 |
include fever | 15 |
common finding | 15 |
serum potassium | 15 |
susceptible mice | 15 |
neutralizing antibodies | 15 |
small animals | 15 |
host immune | 15 |
chronic cases | 15 |
antemortem diagnosis | 15 |
tumors may | 15 |
good prognosis | 15 |
streptococcus spp | 15 |
standing heat | 15 |
tumor necrosis | 15 |
also develop | 15 |
associated diarrhea | 15 |
cov infection | 15 |
natural infections | 15 |
many animals | 15 |
disease progresses | 15 |
days later | 15 |
inbred mice | 15 |
tissue cysts | 15 |
active ingredient | 15 |
blood may | 15 |
biochemical analysis | 15 |
clinical cases | 15 |
body fluids | 15 |
study reported | 15 |
serum albumin | 15 |
fecal contamination | 15 |
chronic weight | 15 |
receptor binding | 15 |
hypertonic saline | 15 |
respiratory pattern | 15 |
administer supplemental | 15 |
small ruminant | 15 |
soft tissues | 15 |
primary disease | 15 |
gastric contents | 15 |
mannose oligosaccharides | 15 |
suckling mice | 15 |
will become | 15 |
body wall | 15 |
free radical | 15 |
wide range | 15 |
soluble host | 15 |
ventricular tachycardia | 15 |
diagnostic test | 15 |
creatine kinase | 14 |
anaerobic bacteria | 14 |
promotes hiv | 14 |
intestinal strangulation | 14 |
horses may | 14 |
tail docking | 14 |
complete obstruction | 14 |
used successfully | 14 |
may decrease | 14 |
coiled coil | 14 |
fecal examination | 14 |
virus particles | 14 |
stem cell | 14 |
female ferrets | 14 |
cellular immune | 14 |
gastrointestinal mucosa | 14 |
rubber catheter | 14 |
losing enteropathy | 14 |
suture material | 14 |
needle aspirates | 14 |
specific lectin | 14 |
broad spectrum | 14 |
typical clinical | 14 |
usually asymptomatic | 14 |
although one | 14 |
appear normal | 14 |
inflammatory drugs | 14 |
wild mice | 14 |
within normal | 14 |
cardiovascular system | 14 |
mediated immunity | 14 |
food material | 14 |
neoplastic cells | 14 |
diagnostic testing | 14 |
animal care | 14 |
cellular entry | 14 |
young cats | 14 |
organ failure | 14 |
cecal impactions | 14 |
laboratory findings | 14 |
esophageal mucosa | 14 |
tap water | 14 |
toxic effects | 14 |
encephalitis virus | 14 |
western blot | 14 |
carbohydrate binding | 14 |
also affect | 14 |
anal sac | 14 |
rectal examination | 14 |
disease include | 14 |
feeding tube | 14 |
aggressive therapy | 14 |
clinical syndromes | 14 |
neurological disease | 14 |
loss may | 14 |
blood transfusion | 14 |
case report | 14 |
abdominal mass | 14 |
without treatment | 14 |
mucosal repair | 14 |
monoclonal antibodies | 14 |
infection also | 14 |
chronically infected | 14 |
human dc | 14 |
entry receptor | 14 |
wound closure | 14 |
cell death | 14 |
pcr assays | 14 |
factors may | 14 |
extracellular domain | 14 |
blood volume | 14 |
estrous cycle | 14 |
administer gastroprotectant | 14 |
fluid analysis | 14 |
located within | 14 |
affected mice | 14 |
skeletal muscle | 14 |
acute lung | 14 |
van eijk | 14 |
signs vary | 14 |
intermittent colic | 14 |
animal patients | 14 |
will develop | 14 |
cell type | 14 |
otitis interna | 14 |
currently available | 14 |
electrolyte balance | 14 |
human milk | 14 |
fusobacterium necrophorum | 14 |
severe inflammation | 14 |
dengue viruses | 14 |
days postinfection | 14 |
positive selection | 14 |
gas bloat | 14 |
caprine arthritis | 14 |
large number | 14 |
primary cause | 14 |
blood transfusions | 14 |
tissue injury | 14 |
biopsy specimens | 14 |
fresh whole | 14 |
glucose concentration | 14 |
also seen | 14 |
may detect | 14 |
epithelial barrier | 14 |
lung sounds | 14 |
breast milk | 14 |
free water | 14 |
serologic testing | 14 |
burn wounds | 14 |
infected cats | 14 |
cause disease | 14 |
inclusion bodies | 14 |
nasal cavity | 14 |
exercise intolerance | 14 |
treatment involves | 14 |
specific gravity | 14 |
bacterial pathogens | 14 |
connective tissue | 14 |
antibiotics may | 14 |
often seen | 14 |
extension tubing | 14 |
laryngeal paralysis | 14 |
neonatal mice | 14 |
may last | 14 |
pasteurella pneumotropica | 14 |
parietal cells | 14 |
reproductive failure | 14 |
negative results | 14 |
zoonotic disease | 14 |
immunodeficiency viruses | 14 |
viral pathogens | 14 |
also shown | 14 |
expression level | 14 |
united kingdom | 14 |
adult sheep | 14 |
ulcers may | 13 |
less frequently | 13 |
carbohydrate overload | 13 |
hemorrhagic diarrhea | 13 |
subcutaneous tissue | 13 |
pseudomonas aeruginosa | 13 |
often found | 13 |
breed dogs | 13 |
severe dehydration | 13 |
nonregenerative anemia | 13 |
necrosis factor | 13 |
toxoplasma gondii | 13 |
lactate dehydrogenase | 13 |
intestinal mucosal | 13 |
perineal area | 13 |
neurologic disease | 13 |
feline pancreatic | 13 |
taking care | 13 |
aggressive treatment | 13 |
prothrombin time | 13 |
necrotic foci | 13 |
antiemetic drugs | 13 |
known antidote | 13 |
eliminate infection | 13 |
much less | 13 |
greatest risk | 13 |
heparinized saline | 13 |
within weeks | 13 |
sign receptors | 13 |
highly digestible | 13 |
young mice | 13 |
infection occurs | 13 |
breeding colonies | 13 |
fluid administration | 13 |
serum protein | 13 |
judicious use | 13 |
villous atrophy | 13 |
successful treatment | 13 |
facilitate viral | 13 |
units kg | 13 |
occult blood | 13 |
commonly seen | 13 |
term management | 13 |
antibiotic ointment | 13 |
receptors dc | 13 |
media interna | 13 |
tissue samples | 13 |
bodies may | 13 |
scalpel blade | 13 |
cells dc | 13 |
plasma cells | 13 |
possible causes | 13 |
medicine doi | 13 |
commonly occurs | 13 |
ear flush | 13 |
diagnostic peritoneal | 13 |
thoracostomy tube | 13 |
tract infection | 13 |
initial infection | 13 |
serum total | 13 |
blood smears | 13 |
small intestines | 13 |
lateral recumbency | 13 |
clot formation | 13 |
arachidonic acid | 13 |
kg bid | 13 |
dietary changes | 13 |
clostridial diseases | 13 |
magnetic resonance | 13 |
ligand binding | 13 |
serum progesterone | 13 |
studies suggest | 13 |
pregnant animals | 13 |
rectal mucosa | 13 |
adrenal glands | 13 |
administer activated | 13 |
ecchymotic hemorrhages | 13 |
severe diarrhea | 13 |
mammalian cells | 13 |
will show | 13 |
commonly reported | 13 |
two groups | 13 |
pcr test | 13 |
glandular mucosa | 13 |
respiratory infections | 13 |
many species | 13 |
body surface | 13 |
allergy dermatitis | 13 |
severe respiratory | 13 |
particularly important | 13 |
nursing care | 13 |
pulmonary aspergillosis | 13 |
classical signs | 13 |
thermal burns | 13 |
disease associated | 13 |
clinical response | 13 |
secondary infection | 13 |
vaginal cytology | 13 |
oxygen therapy | 13 |
breeding colony | 13 |
normal values | 13 |
cervical esophagus | 13 |
healthy animals | 13 |
analysis may | 13 |
caloric intake | 13 |
intravenous infusion | 13 |
nuclear scintigraphy | 13 |
low ph | 13 |
presenting cells | 13 |
ectromelia virus | 13 |
pleural space | 13 |
wound contamination | 13 |
cesarean section | 13 |
hiv type | 13 |
food intake | 13 |
may vary | 13 |
infected ferrets | 13 |
life span | 13 |
effective means | 13 |
mouse genome | 13 |
brain stem | 13 |
systemic toxemia | 13 |
many tissues | 13 |
clinical features | 13 |
distal small | 13 |
cause acute | 13 |
nasogastric reflux | 13 |
combination therapy | 13 |
pyrantel pamoate | 13 |
contact layer | 13 |
infectious causes | 13 |
packed rbcs | 13 |
viral glycoproteins | 13 |
rapid onset | 13 |
commonly observed | 13 |
urea nitrogen | 13 |
serosal surfaces | 13 |
caseous lymphadenitis | 13 |
animal model | 13 |
blood group | 13 |
glucose levels | 13 |
mutant virus | 13 |
also causes | 13 |
administered orally | 12 |
ventral midline | 12 |
copper deficiency | 12 |
cba pressure | 12 |
particularly useful | 12 |
base status | 12 |
heart disease | 12 |
intestinal injury | 12 |
minute iv | 12 |
molecular weight | 12 |
mice develop | 12 |
may benefit | 12 |
generalized demodicosis | 12 |
viral surface | 12 |
salivary gland | 12 |
cytoplasmic tail | 12 |
pain may | 12 |
mammalian species | 12 |
increased respiratory | 12 |
cell activation | 12 |
definitive treatment | 12 |
may progress | 12 |
acute death | 12 |
expressing dc | 12 |
major cause | 12 |
mesothelial cells | 12 |
flea control | 12 |
clipped area | 12 |
binding activity | 12 |
diagnosis diagnosis | 12 |
almost always | 12 |
goats may | 12 |
receptor antagonist | 12 |
hydration status | 12 |
distemper virus | 12 |
feces may | 12 |
respiratory status | 12 |
transmissible venereal | 12 |
body systems | 12 |
disease characterized | 12 |
usually results | 12 |
experimental infections | 12 |
natural killer | 12 |
mice also | 12 |
hunched posture | 12 |
neck domains | 12 |
host species | 12 |
bovine respiratory | 12 |
thyroid hormone | 12 |
clinical history | 12 |
chronic renal | 12 |
may influence | 12 |
environmental conditions | 12 |
changes may | 12 |
sodium phosphate | 12 |
dental disease | 12 |
may aid | 12 |
hiv trans | 12 |
inflammation may | 12 |
three cats | 12 |
see mouse | 12 |
histopathologic lesions | 12 |
mortality may | 12 |
antiinflammatory drug | 12 |
litter size | 12 |
soft palate | 12 |
interstitial pneumonia | 12 |
highly contagious | 12 |
postmortem examination | 12 |
mortality rate | 12 |
atrial standstill | 12 |
invasive aspergillosis | 12 |
genital tract | 12 |
wbc count | 12 |
abdominal organs | 12 |
cats will | 12 |
growth factors | 12 |
whipworm infestation | 12 |
cardiogenic shock | 12 |
type iii | 12 |
cat may | 12 |
hofbauer cells | 12 |
tumor cells | 12 |
leishmania major | 12 |
subclinical infection | 12 |
histological lesions | 12 |
serum lactate | 12 |
granulomatous inflammation | 12 |
corticosteroid therapy | 12 |
kits may | 12 |
associated host | 12 |
binding specificity | 12 |
surgical techniques | 12 |
study found | 12 |
anesthetic drugs | 12 |
membrane proteins | 12 |
vary depending | 12 |
sterile gloves | 12 |
autogenous vaccines | 12 |
ventral abdomen | 12 |
high morbidity | 12 |
severe colic | 12 |
patient discomfort | 12 |
agents may | 12 |
catheter site | 12 |
different types | 12 |
american ginseng | 12 |
repeated doses | 12 |
glandular tissue | 12 |
rumen wall | 12 |
human liver | 12 |
injury may | 12 |
expression levels | 12 |
also associated | 12 |
blood sample | 12 |
cell subsets | 12 |
may persist | 12 |
cardiac failure | 12 |
normal cats | 12 |
present study | 12 |
usually occur | 12 |
part ii | 12 |
duodenal ulcers | 12 |
much lower | 12 |
mycobacterium bovis | 12 |
increased capillary | 12 |
many different | 12 |
flea allergy | 12 |
nile virus | 12 |
retinal detachment | 12 |
test may | 12 |
dermal exposure | 12 |
metabolic alkalosis | 12 |
large animals | 12 |
prerenal azotemia | 12 |
wild animals | 12 |
proximal enteritis | 12 |
mean arterial | 12 |
free gas | 12 |
nucleic acid | 12 |
novel dendritic | 12 |
proximal small | 12 |
cellular immunity | 12 |
fungal infections | 12 |
lymphocytic choriomeningitis | 12 |
soluble carbohydrates | 12 |
pneumonia may | 12 |
motility patterns | 12 |
tract infections | 12 |
novyi type | 12 |
biochemistry panel | 12 |
underlying causes | 12 |
mucosal blood | 12 |
atrial fibrillation | 12 |
rabies virus | 12 |
muscular dystrophy | 12 |
recent report | 12 |
pressure sores | 12 |
second intention | 12 |
adhesion formation | 12 |
affected dogs | 12 |
early diagnosis | 12 |
infectious virus | 12 |
often reveals | 12 |
often results | 12 |
signs depend | 12 |
much higher | 12 |
may extend | 12 |
colonic hyperplasia | 12 |
later stages | 12 |
retinal degeneration | 12 |
adaptive immunity | 12 |
stomach tube | 12 |
west nile | 12 |
nonspecific signs | 12 |
prevent infection | 12 |
one report | 12 |
opportunistic infections | 12 |
intact male | 12 |
dogs may | 12 |
murine norovirus | 12 |
primary closure | 12 |
hydrostatic pressure | 12 |
cecal impaction | 12 |
dorsal recumbency | 12 |
increase susceptibility | 12 |
gamblin skehel | 12 |
fecal output | 12 |
antigen test | 12 |
chronic pain | 12 |
lectin domain | 12 |
propylene glycol | 11 |
abdominal surgery | 11 |
kg every | 11 |
animals become | 11 |
distress syndrome | 11 |
botanical pss | 11 |
otoscopic examination | 11 |
health status | 11 |
transplantable tumors | 11 |
severe anemia | 11 |
induced illness | 11 |
pasteurella multocida | 11 |
porcine reproductive | 11 |
colloid oncotic | 11 |
envelope proteins | 11 |
chronic infections | 11 |
will result | 11 |
bacterial translocation | 11 |
equine small | 11 |
excessive salivation | 11 |
hours following | 11 |
sialic acids | 11 |
lectins may | 11 |
antibodies directed | 11 |
vascular endothelium | 11 |
supports primary | 11 |
cooling measures | 11 |
pancreatic lipase | 11 |
usually subclinical | 11 |
septic arthritis | 11 |
initial therapy | 11 |
smoke inhalation | 11 |
include chronic | 11 |
chronic progressive | 11 |
cells via | 11 |
concurrent disease | 11 |
southeastern united | 11 |
signs similar | 11 |
include severe | 11 |
described previously | 11 |
portal hypertension | 11 |
promote diuresis | 11 |
tissue sections | 11 |
virus replication | 11 |
thoracic inlet | 11 |
salmonella infection | 11 |
syndrome virus | 11 |
platelet function | 11 |
endoplasmic reticulum | 11 |
helper cell | 11 |
siamese cats | 11 |
kg sc | 11 |
stiff gait | 11 |
tailed deer | 11 |
orogastric tube | 11 |
oral route | 11 |
hemorrhagic disease | 11 |
often occur | 11 |
nk cells | 11 |
liver failure | 11 |
also common | 11 |
inhibitory effect | 11 |
acute necrotizing | 11 |
body ingestion | 11 |
postmortem findings | 11 |
endoscopic examination | 11 |
xanthine oxidase | 11 |
characteristic clinical | 11 |
organism may | 11 |
otherwise healthy | 11 |
signaling pathways | 11 |
ingestion includes | 11 |
animal research | 11 |
genetic variation | 11 |
resonance imaging | 11 |
large intestines | 11 |
see sections | 11 |
virus transmission | 11 |
glucose concentrations | 11 |
antiviral therapy | 11 |
galanthus nivalis | 11 |
cns signs | 11 |
fecal shedding | 11 |
drug therapy | 11 |
prolapsed tissue | 11 |
per cent | 11 |
po sid | 11 |
susceptible animals | 11 |
elevated serum | 11 |
proinflammatory cytokines | 11 |
idiopathic vestibular | 11 |
kg hr | 11 |
highly expressed | 11 |
may display | 11 |
cord compression | 11 |
proliferative bowel | 11 |
mature dendritic | 11 |
respiratory failure | 11 |
german shepherd | 11 |
surgical drainage | 11 |
aspergillus fumigatus | 11 |
serum glucose | 11 |
chronic wasting | 11 |
inflammatory lesions | 11 |
blood products | 11 |
golden retrievers | 11 |
nodes may | 11 |
may serve | 11 |
poor growth | 11 |
giardia spp | 11 |
flea infestation | 11 |
will require | 11 |
serum bile | 11 |
young ferrets | 11 |
patient may | 11 |
gastric lesions | 11 |
infectious synapse | 11 |
staphylococcus spp | 11 |
bite wound | 11 |
edim virus | 11 |
chronic gastritis | 11 |
also increase | 11 |
needle catheter | 11 |
virus produced | 11 |
volatile fatty | 11 |
cord injury | 11 |
viral diseases | 11 |
may die | 11 |
live vaccines | 11 |
increased serum | 11 |
young ruminants | 11 |
left untreated | 11 |
related protein | 11 |
highly sensitive | 11 |
rumen acidosis | 11 |
several times | 11 |
spike glycoprotein | 11 |
virus attachment | 11 |
marburg virus | 11 |
bovine leukemia | 11 |
mycobacterium avium | 11 |
sudden onset | 11 |
small size | 11 |
heartworm antigen | 11 |
organ system | 11 |
maternal immunity | 11 |
pulmonary contusions | 11 |
chemotherapeutic agents | 11 |
arthritis encephalitis | 11 |
temporal bone | 11 |
aspartate aminotransferase | 11 |
klebsiella pneumoniae | 11 |
clinical significance | 11 |
appropriate treatment | 11 |
risk factor | 11 |
diagnostic laboratories | 11 |
rectal biopsy | 11 |
high prevalence | 11 |
kg per | 11 |
intranuclear inclusions | 11 |
plasmacytoid dendritic | 11 |
feline liver | 11 |
growing animals | 11 |
avoid using | 11 |
clinician must | 11 |
prostatic disease | 11 |
intestinal small | 11 |
also effective | 11 |
also used | 11 |
rare cases | 11 |
affected areas | 11 |
mediate cellular | 11 |
public health | 11 |
cases occur | 11 |
lameness may | 11 |
regular insulin | 11 |
elbow hygromas | 11 |
carbohydrate structures | 11 |
well documented | 11 |
evidence suggests | 11 |
multiple sites | 11 |
serum igg | 11 |
female dogs | 11 |
fecal material | 11 |
immediate treatment | 11 |
must also | 11 |
heavy sedation | 11 |
mild diarrhea | 11 |
significant increase | 11 |
will depend | 11 |
mm hepes | 11 |
histological examination | 11 |
sciatic nerve | 11 |
wounds may | 11 |
used extensively | 11 |
infected colonies | 11 |
bile ducts | 11 |
gastric decontamination | 11 |
neutralizing antibody | 11 |
may prove | 11 |
mixed infections | 11 |
serum concentrations | 11 |
caudal vena | 11 |
median survival | 11 |
refractory cases | 11 |
aortic arch | 11 |
stratified squamous | 11 |
derived free | 11 |
difficile infection | 11 |
spina bifida | 10 |
parainfluenza virus | 10 |
one suspects | 10 |
normal tissue | 10 |
esophageal irritation | 10 |
dengue infection | 10 |
ehrlichia platys | 10 |
typically associated | 10 |
sendai virus | 10 |
dirofilaria immitis | 10 |
affected individuals | 10 |
cats include | 10 |
affinity binding | 10 |
animal internal | 10 |
imaging features | 10 |
status epilepticus | 10 |
fluid support | 10 |
epithelial restitution | 10 |
transgenic mice | 10 |
edema may | 10 |
fracture site | 10 |
prostate gland | 10 |
mucosal surface | 10 |
may exist | 10 |
two different | 10 |
antimicrobial agents | 10 |
radiographic signs | 10 |
ultrasonography may | 10 |
disease will | 10 |
border disease | 10 |
neonatal foals | 10 |
immune regulation | 10 |
canine parvovirus | 10 |
transmembrane domain | 10 |
blood collection | 10 |
syphacia obvelata | 10 |
inflammatory conditions | 10 |
class ii | 10 |
receptor dc | 10 |
culture results | 10 |
colonic inflammation | 10 |
usually seen | 10 |
giardia duodenalis | 10 |
thorough physical | 10 |
acid production | 10 |
petechial hemorrhages | 10 |
hepatitis virus | 10 |
gastric fluid | 10 |
sample collection | 10 |
will eventually | 10 |
pulmonary parenchymal | 10 |
progressive pneumonia | 10 |
may promote | 10 |
burn wound | 10 |
fever may | 10 |
contact system | 10 |
inciting cause | 10 |
agar gel | 10 |
mediated hemolytic | 10 |
nude mice | 10 |
infected dams | 10 |
causes include | 10 |
cellophane tape | 10 |
condition may | 10 |
mouse hepatitis | 10 |
bacteria may | 10 |
drug resistance | 10 |
dairy goats | 10 |
systemic effects | 10 |
typically occurs | 10 |
sign binds | 10 |
portal vein | 10 |
mycoplasma spp | 10 |
ionized calcium | 10 |
pasteurella haemolytica | 10 |
viral transmission | 10 |
clinical findings | 10 |
gastric disease | 10 |
necrotizing vasculitis | 10 |
aged mice | 10 |
posterior paresis | 10 |
sporulated oocysts | 10 |
fluid secretion | 10 |
sign mediate | 10 |
athymic nude | 10 |
vascular injury | 10 |
proximal jejunitis | 10 |
times per | 10 |
type glycans | 10 |
research council | 10 |
anthelmintic resistance | 10 |
specific plant | 10 |
induced diarrhea | 10 |
specific antibodies | 10 |
treatment regimen | 10 |
ventilation may | 10 |
close proximity | 10 |
ulcerative dermatitis | 10 |
encephalitic form | 10 |
lcmv infection | 10 |
ulcer formation | 10 |
cov spike | 10 |
specific hiv | 10 |
enteric disease | 10 |
older horses | 10 |
biochemical profile | 10 |
renal damage | 10 |
electrolyte solutions | 10 |
lethal infection | 10 |
will appear | 10 |
foreign material | 10 |
intestinal foreign | 10 |
bulla osteotomy | 10 |
abnormalities include | 10 |
diagnostic procedures | 10 |
antibody test | 10 |
bile salt | 10 |
influenza viruses | 10 |
signs seen | 10 |
pathologic changes | 10 |
alveolar spaces | 10 |
viral load | 10 |
every weeks | 10 |
conservative management | 10 |
surgical repair | 10 |
indwelling catheters | 10 |
herd management | 10 |
eosinophilic gastroenteritis | 10 |
reports suggest | 10 |
pet rodents | 10 |
whereas others | 10 |
gastrointestinal system | 10 |
without diarrhea | 10 |
deeper tissues | 10 |
postoperative period | 10 |
stab incision | 10 |
receptor antagonists | 10 |
po bid | 10 |
skin around | 10 |
intestinal tissue | 10 |
mus musculus | 10 |
converting enzyme | 10 |
acute inflammation | 10 |
attachment receptors | 10 |
viral membrane | 10 |
anesthetic depth | 10 |
tracheal collapse | 10 |
will provide | 10 |
gastric rupture | 10 |
respiratory rates | 10 |
dietary fiber | 10 |
masses may | 10 |
pcr assay | 10 |
primary human | 10 |
well tolerated | 10 |
mouse parvovirus | 10 |
including humans | 10 |
infectious tracheobronchitis | 10 |
may demonstrate | 10 |
peritoneal dialysis | 10 |
viral uptake | 10 |
esophageal disease | 10 |
two horses | 10 |
older mice | 10 |
hiv envelope | 10 |
widely used | 10 |
oral antibiotics | 10 |
host factors | 10 |
skin wounds | 10 |
noncardiogenic pulmonary | 10 |
tract obstruction | 10 |
impression smears | 10 |
pleural cavity | 10 |
within several | 10 |
serum calcium | 10 |
cell receptor | 10 |
copious amounts | 10 |
protective role | 10 |
temporary tracheostomy | 10 |
mucosal cells | 10 |
affected limb | 10 |
intestinal lumen | 10 |
least weeks | 10 |
petrous temporal | 10 |
lyme disease | 10 |
mannose glycans | 10 |
severe pain | 10 |
area may | 10 |
crystal structures | 10 |
topical application | 10 |
inflammatory responses | 10 |
clinically affected | 10 |
obstruction may | 10 |
vascular endothelial | 10 |
proximal duodenum | 10 |
administer broad | 10 |
highly susceptible | 10 |
equine colic | 10 |
may reflect | 10 |
gastrointestinal signs | 10 |
thoracic cavity | 10 |
virus strain | 10 |
survey radiographs | 10 |
asymptomatic carriers | 10 |
attachment factors | 10 |
veterinary ophthalmologist | 10 |
viral antigen | 10 |
lung lobes | 10 |
colloid fluids | 10 |
bacterial toxins | 10 |
peritoneal macrophages | 10 |
protein levels | 10 |
wound care | 10 |
associated molecular | 10 |
electrolyte status | 10 |
diarrheal disease | 10 |
monocytic ehrlichiosis | 10 |
access ports | 10 |
type infection | 10 |
cell entry | 10 |
serum sodium | 10 |
bile acid | 10 |
levels may | 10 |
cardiovascular support | 10 |
thyroid gland | 10 |
contractile activity | 10 |
intravenous administration | 10 |
selective recognition | 10 |
fibrinogen concentration | 10 |
viral lectin | 10 |
water bottles | 10 |
taylor drickamer | 10 |
elevated liver | 10 |
alpha toxin | 10 |
complete physical | 10 |
gastrointestinal lymphoma | 10 |
inbred mouse | 10 |
late pregnancy | 10 |
like organisms | 10 |
colon volvulus | 10 |
diagnostic work | 10 |
national research | 10 |
lower motor | 10 |
spinal reflexes | 10 |
several factors | 10 |
cellular proteins | 10 |
acute mastitis | 10 |
may make | 10 |
case series | 10 |
cell differentiation | 10 |
activating factor | 10 |
alimentary lymphosarcoma | 10 |
transitional cell | 10 |
necrotic tissue | 10 |
platelet aggregation | 10 |
initial wound | 10 |
colostral antibodies | 10 |
maintenance fluid | 10 |
urinary incontinence | 10 |
may reach | 10 |
wound may | 10 |
gastric reflux | 10 |
bile salts | 10 |
novel coronavirus | 10 |
iv slowly | 10 |
signs develop | 10 |
many viruses | 10 |
nerve paralysis | 10 |
viral spread | 10 |
atrioventricular block | 9 |
often recommended | 9 |
include acute | 9 |
fecal pcr | 9 |
membrane color | 9 |
venous pressure | 9 |
mediates dengue | 9 |
gastric ulcer | 9 |
infection include | 9 |
inflammatory process | 9 |
bite paralysis | 9 |
negative energy | 9 |
partial thromboplastin | 9 |
invasive fungal | 9 |
pancreatic inflammation | 9 |
hair follicles | 9 |
protein kinase | 9 |
incisor teeth | 9 |
fetal death | 9 |
murine colonic | 9 |
energy balance | 9 |
either side | 9 |
protein glycosylation | 9 |
neurologic examination | 9 |
reverse transcriptase | 9 |
management practices | 9 |
patent airway | 9 |
quality control | 9 |
ii transmembrane | 9 |
clinical use | 9 |
emergency management | 9 |
express dc | 9 |
mhv infection | 9 |
triple antibiotic | 9 |
may improve | 9 |
outflow obstruction | 9 |
surface proteins | 9 |
colon may | 9 |
hiv activity | 9 |
fluid resuscitation | 9 |
take several | 9 |
lens luxation | 9 |
clinically significant | 9 |
virus infectivity | 9 |
auxiliary calcium | 9 |
fluid deficit | 9 |
intestinal flora | 9 |
cell proliferation | 9 |
os penis | 9 |
signs resolve | 9 |
occur via | 9 |
dilated cardiomyopathy | 9 |
reproductive performance | 9 |
help reduce | 9 |
first line | 9 |
hemorrhage may | 9 |
respiratory difficulty | 9 |
base balance | 9 |
include depression | 9 |
nutritional requirements | 9 |
lateral saphenous | 9 |
causes acute | 9 |
hiv transmission | 9 |
hematopoietic system | 9 |
skin may | 9 |
aspiration pneumonitis | 9 |
receptor blockers | 9 |
viral isolation | 9 |
crucial role | 9 |
studies indicate | 9 |
intrinsic renal | 9 |
body cavity | 9 |
repeat region | 9 |
respiratory infection | 9 |
intestinal epithelium | 9 |
feed intake | 9 |
cell function | 9 |
csf analysis | 9 |
thorough history | 9 |
animal products | 9 |
indirect contact | 9 |
viral infectivity | 9 |
occur following | 9 |
situ hybridization | 9 |
genetic variants | 9 |
usually based | 9 |
pulmonary surfactant | 9 |
diarrhea associated | 9 |
tick bites | 9 |
enhances trans | 9 |
toxic changes | 9 |
study demonstrated | 9 |
wound therapy | 9 |
rough hair | 9 |
purulent exudate | 9 |
cardiac silhouette | 9 |
pomegranate sign | 9 |
insect cells | 9 |
factors associated | 9 |
administered intravenously | 9 |
usually develop | 9 |
tidal carbon | 9 |
viral transfer | 9 |
prominent role | 9 |
occur without | 9 |
care may | 9 |
hard palate | 9 |
lesions occur | 9 |
biochemistry profile | 9 |
bismuth subsalicylate | 9 |
urine specific | 9 |
different cell | 9 |
affinity chromatography | 9 |
lipase immunoreactivity | 9 |
invasive pulmonary | 9 |
intestinal diseases | 9 |
hydrogen peroxide | 9 |
will exhibit | 9 |
abdominal paracentesis | 9 |
see appendix | 9 |
transmission may | 9 |
elbow hygroma | 9 |
inhibit hiv | 9 |
serological tests | 9 |
acute gastrointestinal | 9 |
gastric foreign | 9 |
lectin expression | 9 |
gastrointestinal foreign | 9 |
common form | 9 |
adhesive tape | 9 |
gram positive | 9 |
peritoneal effusion | 9 |
respiratory acidosis | 9 |
protective effects | 9 |
thoracic auscultation | 9 |
common sign | 9 |
prokinetic drugs | 9 |
dba mice | 9 |
tube feeding | 9 |
pain associated | 9 |
intestinal anaphylaxis | 9 |
brain tissue | 9 |
many patients | 9 |
capillary permeability | 9 |
skin surface | 9 |
diagnostic methods | 9 |
intracranial pressure | 9 |
intestinal bacterial | 9 |
mortality rates | 9 |
dark red | 9 |
underlying disorder | 9 |
dendritic cellspecific | 9 |
transmissible murine | 9 |
individual animals | 9 |
radiographic findings | 9 |
hypothyroid dogs | 9 |
sphincter tone | 9 |
aortic thromboembolism | 9 |
cervical region | 9 |
oxygen supplementation | 9 |
surface glycoproteins | 9 |
male ferrets | 9 |
clinicopathologic findings | 9 |
abscess formation | 9 |
lawsonia intracellularis | 9 |
thoracic duct | 9 |
core body | 9 |
primary means | 9 |
immature dcs | 9 |
genetically engineered | 9 |
generation cephalosporin | 9 |
local tissue | 9 |
immunofluorescent antibody | 9 |
guinea pig | 9 |
rumen fluid | 9 |
tubular epithelium | 9 |
immune status | 9 |
free radicals | 9 |
human contact | 9 |
infection must | 9 |
gastric outflow | 9 |
research environment | 9 |
partial thickness | 9 |
antiviral immunity | 9 |
adult cats | 9 |
hour period | 9 |
individual animal | 9 |
mass spectrometry | 9 |
virus infections | 9 |
minute virus | 9 |
rubella virus | 9 |
may inhibit | 9 |
following infection | 9 |
lymphatic vessels | 9 |
bluetongue virus | 9 |
reportable disease | 9 |
gas distention | 9 |
thromboplastin time | 9 |
chronic vomiting | 9 |
become infective | 9 |
death occurs | 9 |
mediated disease | 9 |
system may | 9 |
chronic form | 9 |
spinal lymphosarcoma | 9 |
mass lesions | 9 |
endothelial permeability | 9 |
sulfa drugs | 9 |
develop diarrhea | 9 |
wall thickness | 9 |
igm titers | 9 |
pancreatic duct | 9 |
hypersensitivity reaction | 9 |
appropriate antibiotic | 9 |
rodenticide intoxication | 9 |
uncomplicated diarrhea | 9 |
grain overload | 9 |
accurate diagnosis | 9 |
pericardial effusion | 9 |
pancreatic disease | 9 |
feline pancreatitis | 9 |
oral inoculation | 9 |
transfusion reaction | 9 |
will increase | 9 |
internal organs | 9 |
lymphoid organs | 9 |
surgery may | 9 |
ehrlichia canis | 9 |
include lethargy | 9 |
abnormalities may | 9 |
surface receptors | 9 |
advanced imaging | 9 |
protein expression | 9 |
peripheral edema | 9 |
cytomegalovirus binding | 9 |
damage may | 9 |
strongylus vulgaris | 9 |
characteristic lesions | 9 |
also present | 9 |
regenerative anemia | 9 |
rib fractures | 9 |
usually found | 9 |
intermediate layer | 9 |
take place | 9 |
intravenous extension | 9 |
diagnostic approach | 9 |
bovine serum | 9 |
efficiently infect | 9 |
inflammatory reaction | 9 |
strangulating lesions | 9 |
trefoil peptides | 9 |
low numbers | 9 |
toxicity includes | 9 |
draining tracts | 9 |
lower respiratory | 9 |
clinical syndrome | 9 |
hemolytic crisis | 9 |
lectin activity | 9 |
host icam | 9 |
infection dc | 9 |
definitive hosts | 9 |
derived dcs | 9 |
protective effect | 9 |
cellular receptors | 9 |
severe metabolic | 9 |
blood clots | 9 |
liver sinusoidal | 9 |
ensure adequate | 9 |
wasting disease | 9 |
critical role | 9 |
pain relief | 9 |
canine population | 9 |
parenchymal disease | 9 |
less effective | 9 |
extremely important | 9 |
takes place | 9 |
von willebrand | 9 |
signs usually | 9 |
affected bowel | 9 |
active infection | 9 |
tube may | 9 |
feline leukemia | 9 |
indwelling catheter | 9 |
will decrease | 9 |
binding affinity | 9 |
adult cattle | 9 |
research colonies | 9 |
early recognition | 9 |
gp envelope | 9 |
common signs | 9 |
histocompatibility complex | 9 |
days old | 9 |
surface receptor | 9 |
hematologic abnormalities | 9 |
affected horses | 9 |
neonatal ruminants | 9 |
white tape | 9 |
fecal occult | 9 |
leishmania species | 9 |
see adrenal | 9 |
infection causes | 9 |
class i | 9 |
carbohydrate absorption | 9 |
previous reports | 9 |
dog breeds | 9 |
emptying defect | 9 |
also include | 9 |
case reports | 9 |
binding properties | 9 |
promoter polymorphism | 9 |
feedlot lambs | 9 |
platelet counts | 9 |
pelvic limbs | 9 |
virus glycoproteins | 9 |
inflamed tissues | 9 |
anal sacs | 9 |
myeloid cells | 9 |
cell transplantation | 9 |
intracellular signaling | 9 |
thermal injury | 9 |
joint pain | 9 |
occur anywhere | 9 |
mononuclear cell | 9 |
embryonic death | 9 |
necropsy lesions | 9 |
following formula | 9 |
intestinal surgery | 9 |
inflammatory agents | 9 |
progesterone levels | 9 |
cell interactions | 9 |
skehel wiley | 9 |
pump inhibitors | 9 |
cell trans | 9 |
cardiopulmonary arrest | 9 |
large volume | 9 |
prolonged capillary | 9 |
per minute | 9 |
sensory nerves | 9 |
tissue culture | 9 |
new zealand | 9 |
systemic hypertension | 9 |
fluids containing | 9 |
glycan decoys | 9 |
novel protein | 9 |
multiple organ | 9 |
may resolve | 9 |
humoral immune | 9 |
biochemical abnormalities | 9 |
immediate surgical | 9 |
blood smear | 9 |
estrogen toxicity | 9 |
gel immunodiffusion | 9 |
cheek tooth | 9 |
phosphate dehydrogenase | 9 |
brain barrier | 9 |
care includes | 9 |
one hand | 9 |
ventricular fibrillation | 9 |
left dorsal | 9 |
molecular patterns | 9 |
negative sepsis | 9 |
intestinal ileus | 9 |
glycans may | 9 |
signs clinical | 9 |
also useful | 9 |
right side | 9 |
mediated trans | 9 |
mucosal hyperplasia | 8 |
decubital ulcers | 8 |
affected animal | 8 |
lmn urinary | 8 |
severe infestations | 8 |
respiratory function | 8 |
radiographic evidence | 8 |
mammary tissue | 8 |
abdominal neoplasia | 8 |
health inspection | 8 |
knockout mice | 8 |
external trauma | 8 |
anterior uveitis | 8 |
sign neck | 8 |
usually made | 8 |
cecal emptying | 8 |
small numbers | 8 |
oxygen administration | 8 |
egg antigens | 8 |
intestinal ischemia | 8 |
three carbohydrate | 8 |
fibrin degradation | 8 |
die within | 8 |
hydrochloric acid | 8 |
concentrated human | 8 |
often causes | 8 |
molecular basis | 8 |
puncture wounds | 8 |
collect blood | 8 |
cause obstruction | 8 |
parietal cell | 8 |
susceptibility factors | 8 |
wearing sterile | 8 |
intestinal epithelial | 8 |
floppy kid | 8 |
gi disease | 8 |
humidified oxygen | 8 |
food bolus | 8 |
will generally | 8 |
may arise | 8 |
high level | 8 |
nasal secretions | 8 |
pet ferrets | 8 |
cardiac contractility | 8 |
approximately cm | 8 |
hair regrowth | 8 |
mannose binding | 8 |
derived dengue | 8 |
chain fatty | 8 |
cold water | 8 |
continuous infusion | 8 |
kidney disease | 8 |
contagious disease | 8 |
airway disease | 8 |
motor vehicle | 8 |
pneumonia virus | 8 |
two forms | 8 |
dexamethasone sodium | 8 |
gastrointestinal parasites | 8 |
also result | 8 |
prevent contamination | 8 |
complications associated | 8 |
per se | 8 |
spinal trauma | 8 |
negative rod | 8 |
intoxication include | 8 |
first described | 8 |
hepatic necrosis | 8 |
transmissible gastroenteritis | 8 |
nasogastric intubation | 8 |
metabolic disease | 8 |
left atrium | 8 |
natural transmission | 8 |
respond well | 8 |
signr interact | 8 |
organ perfusion | 8 |
iv tid | 8 |
equine peritoneal | 8 |
water loss | 8 |
ongoing hemorrhage | 8 |
electrolyte solution | 8 |
perfusion parameters | 8 |
research facilities | 8 |
necrotizing pancreatitis | 8 |
mucosa may | 8 |
independent binding | 8 |
pain management | 8 |
left side | 8 |
suckle reflex | 8 |
gland adenocarcinoma | 8 |
adrenal disease | 8 |
subcutaneously every | 8 |
binding capacity | 8 |
recent work | 8 |